Epigenetic regulation in neurodevelopment and neurodegenerative diseases

Neuroscience

Volumn 264, Issue , 2014, Pages 99-111

  Gapp, K ^a   Woldemichael, B T ^a   Bohacek, J ^a   Mansuy, I M ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Alzheimer's disease; Epigenetics; Huntington's disease; Imprinting disorders; Neurodevelopment; Parkinson's disease

Indexed keywords

DNA METHYLTRANSFERASE; GLIAL FIBRILLARY ACIDIC PROTEIN; METHYL CPG BINDING PROTEIN 2; PROTEIN S100B;

AGING; ALZHEIMER DISEASE; BECKWITH WIEDEMANN SYNDROME; BRAIN CELL; CELL FUNCTION; CELL MATURATION; COGNITIVE DEFECT; CPG ISLAND; DEGENERATIVE DISEASE; DNA METHYLATION; EMBRYO DEVELOPMENT; EPIGENETICS; GENETIC REGULATION; GENOME IMPRINTING; GENOTYPE ENVIRONMENT INTERACTION; HAPPY PUPPET SYNDROME; HISTONE MODIFICATION; HUMAN; HUNTINGTON CHOREA; MEMORY CONSOLIDATION; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTEIN PROCESSING; RETT SYNDROME; REVIEW;

ALZHEIMER'S DISEASE; EPIGENETICS; HUNTINGTON'S DISEASE; IMPRINTING DISORDERS; NEURODEVELOPMENT; PARKINSON'S DISEASE;

ANIMALS; BRAIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENESIS, GENETIC; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS;

EID: 84895897607     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.11.040     Document Type: Review

References (179)

1. Alberio T., Lopiano L., Fasano M. Cellular models to investigate biochemical pathways in Parkinson's disease. FEBS J 2012, 279:1146-1155.
2. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23:185-188.
3. Arrowsmith C.H., Bountra C., Fish P.V., Lee K., Schapira M. Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 2012, 11:384-400.
4. Attia M., Rachez C., De Pauw A., Avner P., Rogner U.C. Nap1l2 promotes histone acetylation activity during neuronal differentiation. Mol Cell Biol 2007, 27:6093-6102.
5. Bai S., Ghoshal K., Datta J., Majumder S., Yoon S.O., Jacob S.T. DNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2. Mol Cell Biol 2005, 25:751-766.
6. Ballas N., Grunseich C., Lu D.D., Speh J.C., Mandel G. REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 2005, 121:645-657.
7. Ballas N., Lioy D.T., Grunseich C., Mandel G. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 2009, 12:311-317.
8. Bates G.P. History of genetic disease: the molecular genetics of Huntington disease - a history. Nat Rev Genet 2005, 6:766-773.
9. Ben-Shachar S., Chahrour M., Thaller C., Shaw C.A., Zoghbi H.Y. Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet 2009, 18:2431-2442.
10. Berni Canani R., Di Costanzo M., Leone L. The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin Epigenetics 2012, 4:4.
11. Bertram L., Lill C.M., Tanzi R.E. The genetics of Alzheimer disease: back to the future. Neuron 2010, 68:270-281.
12. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16:6-21.
13. Blackman M.P., Djukic B., Nelson S.B., Turrigiano G.G. A critical and cell-autonomous role for MeCP2 in synaptic scaling up. J Neurosci 2012, 32:13529-13536.
14. Blalock E.M., Chen K.-C., Sharrow K., Herman J.P., Porter N., Foster T., Landfield P. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 2003, 23:3807-3819.
15. Bohacek J., Mansuy I.M. Epigenetic inheritance of disease and disease risk. Neuropsychopharmacology 2013, 38:220-236.
16. Bollati V., Galimberti D., Pergoli L., Dalla Valle E., Barretta F., Cortini F., Scarpini E., Bertazzi P.A., Baccarelli A. DNA methylation in repetitive elements and Alzheimer disease. Brain Behav Immun 2011, 25:1078-1083.
17. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
18. Branco M.R., Ficz G., Reik W. Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet 2012, 13:7-13.
19. Brazel C.Y., Romanko M.J., Rothstein R.P., Levison S.W. Roles of the mammalian subventricular zone in brain development. Prog Neurobiol 2003, 69:49-69.
20. Brickell K.L., Leverenz J.B., Steinbart E.J., Rumbaugh M., Schellenberg G.D., Nochlin D., Lampe T.H., Holm I.E., Van Deerlin V., Yuan W., Bird T.D. Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007, 78:1050-1055.
21. Brooks P.J., Marietta C., Goldman D. DNA mismatch repair and DNA methylation in adult brain neurons. J Neurosci 1996, 16:939-945.
22. Brouwers N., Sleegers K., Van Broeckhoven C. Molecular genetics of Alzheimer's disease: an update. Ann Med 2008, 40:562-583.
23. Brunner A.M., Tweedie-Cullen R.Y., Mansuy I.M. Epigenetic modifications of the neuroproteome. Proteomics 2012, 14. 201100672.
24. Burgold T., Spreafico F., De Santa F., Totaro M.G., Prosperini E., Natoli G., Testa G. The histone H3 lysine 27-specific demethylase Jmjd3 is required for neural commitment. PLoS One 2008, 3:e3034.
25. Burns A., Iliffe S. Alzheimer's disease. BMJ 2009, 338:b158.
26. Cao X., Sudhof T.C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001, 293:115-120.
27. Cassidy S.B., Dykens E., Williams C.A. Prader-Willi and Angelman syndromes: sister imprinted disorders. Am J Med Genet 2000, 97:136-146.
28. Castellano J.F., Fletcher B.R., Kelley-Bell B., Kim D.H., Gallagher M., Rapp P.R. Age-related memory impairment is associated with disrupted multivariate epigenetic coordination in the hippocampus. PLoS One 2012, 7:e33249.
29. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., Zoghbi H.Y. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229.
30. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 2007, 56:422-437.
31. Chamberlain S.J., Lalande M. Angelman syndrome, a genomic imprinting disorder of the brain. J Neurosci 2010, 30:9958-9963.
32. Chamberlain S.J., Lalande M. Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11-q13. Neurobiol Dis 2010, 39:13-20.
33. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001, 27:327-331.
34. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., Griffith E.C., Jaenisch R., Greenberg M.E. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003, 302:885-889.
35. Cohen S., Gabel H.W., Hemberg M., Hutchinson A.N., Sadacca L.A., Ebert D.H., Harmin D.A., Greenberg R.S., Verdine V.K., Zhou Z., Wetsel W.C., West A.E., Greenberg M.E. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 2011, 72:72-85.
36. Collins A.L., Levenson J.M., Vilaythong A.P., Richman R., Armstrong D.L., Noebels J.L., David Sweatt J., Zoghbi H.Y. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 2004, 13:2679-2689.
37. Coppede F. Genetics and epigenetics of Parkinson's disease. ScientificWorldJournal 2012, 2012:489830.
38. Crews L., Masliah E. Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet 2010, 19:R12-R20.
39. Cruchaga C., Chakraverty S., Mayo K., Vallania F.L., Mitra R.D., Faber K., Williamson J., Bird T., Diaz-Arrastia R., Foroud T.M., Boeve B.F., Graff-Radford N.R., St Jean P., Lawson M., Ehm M.G., Mayeux R., Goate A.M. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One 2012, 7:e31039.
40. Davies M.N., Volta M., Pidsley R., Lunnon K., Dixit A., Lovestone S., Coarfa C., Harris R.A., Milosavljevic A., Troakes C., Al-Sarraj S., Dobson R., Schalkwyk L.C., Mill J. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 2012, 13:R43.
41. De Jager P, Srivatsava G, Eaton M, Chibnik L, Kellis M, Bennett D (2012) Genome-wide exploration of DNA methylation in the aging brain and its relation to Alzheimer's disease. Neurology 78(April (Meeting Abstracts 1)): P05070.
42. Devine M.J., Kaganovich A., Ryten M., Mamais A., Trabzuni D., Manzoni C., McGoldrick P., Chan D., Dillman A., Zerle J., Horan S., Taanman J.W., Hardy J., Marti-Masso J.F., Healy D., Schapira A.H., Wolozin B., Bandopadhyay R., Cookson M.R., van der Brug M.P., Lewis P.A. Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue. PLoS One 2011, 6:e22489.
43. Elbaz A., Moisan F. Parkinson's disease: is there a strong environmental contribution?. Rev Neurol (Paris) 2010, 166:757-763.
44. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007, 8:286-298.
45. Fabel K., Wolf S.A., Ehninger D., Babu H., Leal-Galicia P., Kempermann G. Additive effects of physical exercise and environmental enrichment on adult hippocampal neurogenesis in mice. Front Neurosci 2009, 3:50.
46. Fan G., Martinowich K., Chin M.H., He F., Fouse S.D., Hutnick L., Hattori D., Ge W., Shen Y., Wu H., ten Hoeve J., Shuai K., Sun Y.E. DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling. Development 2005, 132:3345-3356.
47. Fasano C.A., Phoenix T.N., Kokovay E., Lowry N., Elkabetz Y., Dimos J.T., Lemischka I.R., Studer L., Temple S. Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain. Genes Dev 2009, 23:561-574.
48. Fazzari M.J., Greally J.M. Introduction to epigenomics and epigenome-wide analysis. Methods Mol Biol 2010, 620:243-265.
49. Feinberg A.P., Irizarry R.A. Evolution in health and medicine Sackler colloquium: stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease. Proc Natl Acad Sci U S A 2010, 107:1757-1764.
50. Feng J., Chang H., Li E., Fan G. Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system. J Neurosci Res 2005, 79:734-746.
51. Feng J., Fouse S., Fan G. Epigenetic regulation of neural gene expression and neuronal function. Pediatr Res 2007, 61:58R-63R.
52. Feng J., Zhou Y., Campbell S.L., Le T., Li E., Sweatt J.D., Silva A.J., Fan G. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 2010, 13:423-430.
53. Ferrante R.J., Kubilus J.K., Lee J., Ryu H., Beesen A., Zucker B., Smith K., Kowall N.W., Ratan R.R., Luthi-Carter R., Hersch S.M. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 2003, 23:9418-9427.
54. Ferrante R.J., Ryu H., Kubilus J.K., D'Mello S., Sugars K.L., Lee J., Lu P., Smith K., Browne S., Beal M.F., Kristal B.S., Stavrovskaya I.G., Hewett S., Rubinsztein D.C., Langley B., Ratan R.R. Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease. J Neurosci 2004, 24:10335-10342.
55. Fischer A., Sananbenesi F., Wang X., Dobbin M., Tsai L.H. Recovery of learning and memory is associated with chromatin remodelling. Nature 2007, 447:178-182.
56. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., Heine-Suner D., Cigudosa J.C., Urioste M., Benitez J., Boix-Chornet M., Sanchez-Aguilera A., Ling C., Carlsson E., Poulsen P., Vaag A., Stephan Z., Spector T.D., Wu Y.Z., Plass C., Esteller M. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 2005, 102:10604-10609.
57. Francis Y.I., Fa M., Ashraf H., Zhang H., Staniszewski A., Latchman D.S., Arancio O. Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease. J Alzheimers Dis 2009, 18:131-139.
58. Fuks F., Hurd P.J., Wolf D., Nan X., Bird A.P., Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 2003, 278:4035-4040.
59. Gao Z., Ure K., Ding P., Nashaat M., Yuan L., Ma J., Hammer R.E., Hsieh J. The master negative regulator REST/NRSF controls adult neurogenesis by restraining the neurogenic program in quiescent stem cells. J Neurosci 2011, 31:9772-9786.
60. Gardian G., Browne S.E., Choi D.K., Klivenyi P., Gregorio J., Kubilus J.K., Ryu H., Langley B., Ratan R.R., Ferrante R.J., Beal M.F. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem 2005, 280:556-563.
61. Gonzales M.L., Adams S., Dunaway K.W., LaSalle J.M. Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation. Mol Cell Biol 2012, 32:2894-2903.
62. Goto K., Numata M., Komura J.I., Ono T., Bestor T.H., Kondo H. Expression of DNA methyltransferase gene in mature and immature neurons as well as proliferating cells in mice. Differentiation 1994, 56:39-44.
63. Gräff J., Mansuy I.M. Epigenetic codes in cognition and behaviour. Behav Brain Res 2008, 192:70-87.
64. Gräff J., Woldemichael B.T., Berchtold D., Dewarrat G., Mansuy I.M. Dynamic histone marks in the hippocampus and cortex facilitate memory consolidation. Nat Commun 2012, 3:991.
65. Gunzburg M.J., Perugini M.A., Howlett G.J. Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E. J Biol Chem 2007, 282:35831-35841.
66. Guy J., Gan J., Selfridge J., Cobb S., Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315:1143-1147.
67. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001, 27:322-326.
68. Hansen K.D., Timp W., Bravo H.C., Sabunciyan S., Langmead B., McDonald O.G., Wen B., Wu H., Liu Y., Diep D., Briem E., Zhang K., Irizarry R.A., Feinberg A.P. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 2011, 43:768-775.
69. He F., Todd P.K. Epigenetics in nucleotide repeat expansion disorders. Semin Neurol 2011, 31:470-483.
70. He Y., Sandoval J., Casaccia-Bonnefil P. Events at the transition between cell cycle exit and oligodendrocyte progenitor differentiation: the role of HDAC and YY1. Neuron Glia Biol 2007, 3:221-231.
71. Hernandez D.G., Nalls M.A., Gibbs J.R., Arepalli S., van der Brug M., Chong S., Moore M., Longo D.L., Cookson M.R., Traynor B.J., Singleton A.B. Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum Mol Genet 2011, 20:1164-1172.
72. Hirabayashi Y., Gotoh Y. Epigenetic control of neural precursor cell fate during development. Nat Rev Neurosci 2010, 11:377-388.
73. Hockly E., Richon V.M., Woodman B., Smith D.L., Zhou X., Rosa E., Sathasivam K., Ghazi-Noori S., Mahal A., Lowden P.A., Steffan J.S., Marsh J.L., Thompson L.M., Lewis C.M., Marks P.A., Bates G.P. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A 2003, 100:2041-2046.
74. Hsieh J., Nakashima K., Kuwabara T., Mejia E., Gage F.H. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci U S A 2004, 101:16659-16664.
75. Hutnick L.K., Golshani P., Namihira M., Xue Z., Matynia A., Yang X.W., Silva A.J., Schweizer F.E., Fan G. DNA hypomethylation restricted to the murine forebrain induces cortical degeneration and impairs postnatal neuronal maturation. Hum Mol Genet 2009, 18:2875-2888.
76. Iwata N., Tsubuki S., Takaki Y., Watanabe K., Sekiguchi M., Hosoki E., Kawashima-Morishima M., Lee H.J., Hama E., Sekine-Aizawa Y., Saido T.C. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 2000, 6:143-150.
77. Jones P.A., Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001, 293:1068-1070.
78. Jowaed A., Schmitt I., Kaut O., Wullner U. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. J Neurosci 2010, 30:6355-6359.
79. Kaikkonen M.U., Lam M.T., Glass C.K. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 2011, 90:430-440.
80. Kang H.J., Kawasawa Y.I., Cheng F., Zhu Y., Xu X., Li M., Sousa A.M., Pletikos M., Meyer K.A., Sedmak G., Guennel T., Shin Y., Johnson M.B., Krsnik Z., Mayer S., Fertuzinhos S., Umlauf S., Lisgo S.N., Vortmeyer A., Weinberger D.R., Mane S., Hyde T.M., Huttner A., Reimers M., Kleinman J.E., Sestan N. Spatio-temporal transcriptome of the human brain. Nature 2011, 478:483-489.
81. Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., Delalle I., Baur J.A., Sui G., Armour S.M., Puigserver P., Sinclair D.A., Tsai L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 2007, 26:3169-3179.
82. Kim M.O., Chawla P., Overland R.P., Xia E., Sadri-Vakili G., Cha J.H. Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation. J Neurosci 2008, 28:3947-3957.
83. Kinney S.R., Pradhan S. Regulation of expression and activity of DNA (cytosine-5) methyltransferases in mammalian cells. Prog Mol Biol Transl Sci 2011, 101:311-333.
84. Klose R.J., Bird A.P. MeCP2 behaves as an elongated monomer that does not stably associate with the Sin3a chromatin remodeling complex. J Biol Chem 2004, 279:46490-46496.
85. Klose R.J., Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006, 31:89-97.
86. Kontopoulos E., Parvin J.D., Feany M.B. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum Mol Genet 2006, 15:3012-3023.
87. Koshibu K., Graff J., Beullens M., Heitz F.D., Berchtold D., Russig H., Farinelli M., Bollen M., Mansuy I.M. Protein phosphatase 1 regulates the histone code for long-term memory. J Neurosci 2009, 29:13079-13089.
88. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
89. Lahiri D.K., Maloney B., Zawia N.H. The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry 2009, 14:992-1003.
90. Lang A.E., Obeso J.A. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 2004, 3:309-316.
91. Lee E.R., Murdoch F.E., Fritsch M.K. High histone acetylation and decreased polycomb repressive complex 2 member levels regulate gene specific transcriptional changes during early embryonic stem cell differentiation induced by retinoic acid. Stem Cells 2007, 25:2191-2199.
92. Lepagnol-Bestel A.M., Zvara A., Maussion G., Quignon F., Ngimbous B., Ramoz N., Imbeaud S., Loe-Mie Y., Benihoud K., Agier N., Salin P.A., Cardona A., Khung-Savatovsky S., Kallunki P., Delabar J.M., Puskas L.G., Delacroix H., Aggerbeck L., Delezoide A.L., Delattre O., Gorwood P., Moalic J.M., Simonneau M. DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome. Hum Mol Genet 2009, 18:1405-1414.
93. Leung K.N., Chamberlain S.J., Lalande M., LaSalle J.M. Neuronal chromatin dynamics of imprinting in development and disease. J Cell Biochem 2011, 112:365-373.
94. Li W., Calfa G., Larimore J., Pozzo-Miller L. Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice. Proc Natl Acad Sci U S A 2012, 109:17087-17092.
95. Lim D.A., Huang Y.C., Swigut T., Mirick A.L., Garcia-Verdugo J.M., Wysocka J., Ernst P., Alvarez-Buylla A. Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature 2009, 458:529-533.
96. Lioy D.T., Garg S.K., Monaghan C.E., Raber J., Foust K.D., Kaspar B.K., Hirrlinger P.G., Kirchhoff F., Bissonnette J.M., Ballas N., Mandel G. A role for glia in the progression of Rett's syndrome. Nature 2011, 475:497-500.
97. Liu C., Teng Z.Q., Santistevan N.J., Szulwach K.E., Guo W., Jin P., Zhao X. Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. Cell Stem Cell 2010, 6:433-444.
98. Lu T., et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004, 429:883-891.
99. Lundberg J., Karimi M., von Gertten C., Holmin S., Ekstrom T.J., Sandberg-Nordqvist A.C. Traumatic brain injury induces relocalization of DNA-methyltransferase 1. Neurosci Lett 2009, 457:8-11.
100. Lunyak V.V., Burgess R., Prefontaine G.G., Nelson C., Sze S.H., Chenoweth J., Schwartz P., Pevzner P.A., Glass C., Mandel G., Rosenfeld M.G. Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 2002, 298:1747-1752.
101. Lyssiotis C.A., Walker J., Wu C., Kondo T., Schultz P.G., Wu X. Inhibition of histone deacetylase activity induces developmental plasticity in oligodendrocyte precursor cells. Proc Natl Acad Sci U S A 2007, 104:14982-14987.
102. Ma D.K., Jang M.H., Guo J.U., Kitabatake Y., Chang M.L., Pow-Anpongkul N., Flavell R.A., Lu B., Ming G.L., Song H. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 2009, 323:1074-1077.
103. Maezawa I., Swanberg S., Harvey D., LaSalle J.M., Jin L.W. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci 2009, 29:5051-5061.
104. Marambaud P., Wen P.H., Dutt A., Shioi J., Takashima A., Siman R., Robakis N.K. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 2003, 114:635-645.
105. Marin-Husstege M., Muggironi M., Liu A., Casaccia-Bonnefil P. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 2002, 22:10333-10345.
106. Martinowich K., Hattori D., Wu H., Fouse S., He F., Hu Y., Fan G., Sun Y.E. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003, 302:890-893.
107. Mastroeni D., Grover A., Delvaux E., Whiteside C., Coleman P.D., Rogers J. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol Aging 2010, 31:2025-2037.
108. Mikkelsen T.S., Ku M., Jaffe D.B., Issac B., Lieberman E., Giannoukos G., Alvarez P., Brockman W., Kim T.K., Koche R.P., Lee W., Mendenhall E., O'Donovan A., Presser A., Russ C., Xie X., Meissner A., Wernig M., Jaenisch R., Nusbaum C., Lander E.S., Bernstein B.E. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560.
109. Miller C.A., Gavin C.F., White J.A., Parrish R.R., Honasoge A., Yancey C.R., Rivera I.M., Rubio M.D., Rumbaugh G., Sweatt J.D. Cortical DNA methylation maintains remote memory. Nat Neurosci 2010, 13:664-666.
110. Ming G.L., Song H. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 2011, 70:687-702.
111. Mogi M., Harada M., Narabayashi H., Inagaki H., Minami M., Nagatsu T. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile Parkinsonism and Parkinson's disease. Neurosci Lett 1996, 211:13-16.
112. Morrens J., Van Den Broeck W., Kempermann G. Glial cells in adult neurogenesis. Glia 2012, 60:159-174.
113. Mulligan P., Westbrook T.F., Ottinger M., Pavlova N., Chang B., Macia E., Shi Y.J., Barretina J., Liu J., Howley P.M., Elledge S.J., Shi Y. CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation. Mol Cell 2008, 32:718-726.
114. Namihira M., Nakashima K., Taga T. Developmental stage dependent regulation of DNA methylation and chromatin modification in a immature astrocyte specific gene promoter. FEBS Lett 2004, 572:184-188.
115. Narayan P., Dragunow M. Pharmacology of epigenetics in brain disorders. Br J Pharmacol 2010, 159:285-303.
116. Nicholas A.P., Lubin F.D., Hallett P.J., Vattem P., Ravenscroft P., Bezard E., Zhou S., Fox S.H., Brotchie J.M., Sweatt J.D., Standaert D.G. Striatal histone modifications in models of levodopa-induced dyskinesia. J Neurochem 2008, 106:486-494.
117. Niedowicz D.M., Nelson P.T., Murphy M.P. Alzheimer's disease: pathological mechanisms and recent insights. Curr Neuropharmacol 2011, 9:674-684.
118. Outeiro T.F., Kontopoulos E., Altmann S.M., Kufareva I., Strathearn K.E., Amore A.M., Volk C.B., Maxwell M.M., Rochet J.C., McLean P.J., Young A.B., Abagyan R., Feany M.B., Hyman B.T., Kazantsev A.G. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 2007, 317:516-519.
119. Paoloni-Giacobino A., Chaillet J. The role of DMDs in the maintenance of epigenetic states. Cytogenet Genome Res 2006, 113:116-121.
120. Peleg S., Sananbenesi F., Zovoilis A., Burkhardt S., Bahari-Javan S., Agis-Balboa R.C., Cota P., Wittnam J.L., Gogol-Doering A., Opitz L., Salinas-Riester G., Dettenhofer M., Kang H., Farinelli L., Chen W., Fischer A. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 2010, 328:753-756.
121. Penner M.R., Roth T.L., Chawla M.K., Hoang L.T., Roth E.D., Lubin F.D., Sweatt J.D., Worley P.F., Barnes C.A. Age-related changes in Arc transcription and DNA methylation within the hippocampus. Neurobiol Aging 2011, 32:2198-2210.
122. Pieper H.C., Evert B.O., Kaut O., Riederer P.F., Waha A., Wullner U. Different methylation of the TNF-alpha promoter in cortex and substantia nigra: implications for selective neuronal vulnerability. Neurobiol Dis 2008, 32:521-527.
123. Ptak C., Petronis A. Epigenetics and complex disease: from etiology to new therapeutics. Annu Rev Pharmacol Toxicol 2008, 48:257-276.
124. Rouaux C., Jokic N., Mbebi C., Boutillier S., Loeffler J.P., Boutillier A.L. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J 2003, 22:6537-6549.
125. Rowe W.B., et al. Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J Neurosci 2007, 27:3098-3110.
126. Rowe W.B., Blalock E.M., Chen K.C., Kadish I., Wang D., Barrett J.E., Thibault O., Porter N.M., Rose G.M., Landfield P.W. Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J Neurosci 2007, 27:3098-3110.
127. Rutten B.P., Mill J. Epigenetic mediation of environmental influences in major psychotic disorders. Schizophr Bull 2009, 35:1045-1056.
128. Ryu H., Lee J., Hagerty S.W., Soh B.Y., McAlpin S.E., Cormier K.A., Smith K.M., Ferrante R.J. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc Natl Acad Sci U S A 2006, 103:19176-19181.
129. Sadri-Vakili G., Bouzou B., Benn C.L., Kim M.O., Chawla P., Overland R.P., Glajch K.E., Xia E., Qiu Z., Hersch S.M., Clark T.W., Yohrling G.J., Cha J.H. Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Hum Mol Genet 2007, 16:1293-1306.
130. Samaco R.C., McGraw C.M., Ward C.S., Sun Y., Neul J.L., Zoghbi H.Y. Female Mecp2+/- mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies. Hum Mol Genet 2013, 22:96-109.
131. Saura C.A., Choi S.Y., Beglopoulos V., Malkani S., Zhang D., Shankaranarayana Rao B.S., Chattarji S., Kelleher R.J., Kandel E.R., Duff K., Kirkwood A., Shen J. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 2004, 42:23-36.
132. Seong I.S., Woda J.M., Song J.J., Lloret A., Abeyrathne P.D., Woo C.J., Gregory G., Lee J.M., Wheeler V.C., Walz T., Kingston R.E., Gusella J.F., Conlon R.A., MacDonald M.E. Huntingtin facilitates polycomb repressive complex 2. Hum Mol Genet 2010, 19:573-583.
133. Sha K. A mechanistic view of genomic imprinting. Annu Rev Genomics Hum Genet 2008, 9:197-216.
134. Shen S., Li J., Casaccia-Bonnefil P. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J Cell Biol 2005, 169:577-589.
135. Siegmund K.D., Connor C.M., Campan M., Long T.I., Weisenberger D.J., Biniszkiewicz D., Jaenisch R., Laird P.W., Akbarian S. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS One 2007, 2:e895.
136. Sierksma A.S., van den Hove D.L., Steinbusch H.W., Prickaerts J. Major depression, cognitive dysfunction and Alzheimer's disease: is there a link?. Eur J Pharmacol 2009, 626:72-82.
137. Sikorska M., Sandhu J.K., Deb-Rinker P., Jezierski A., Leblanc J., Charlebois C., Ribecco-Lutkiewicz M., Bani-Yaghoub M., Walker P.R. Epigenetic modifications of SOX2 enhancers, SRR1 and SRR2, correlate with in vitro neural differentiation. J Neurosci Res 2008, 86:1680-1693.
138. Silverman J.M., Ciresi G., Smith C.J., Marin D.B., Schnaider-Beeri M. Variability of familial risk of Alzheimer disease across the late life span. Arch Gen Psychiatry 2005, 62:565-573.
139. Smrt R.D., Eaves-Egenes J., Barkho B.Z., Santistevan N.J., Zhao C., Aimone J.B., Gage F.H., Zhao X. Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiol Dis 2007, 27:77-89.
140. Stack E.C., Del Signore S.J., Luthi-Carter R., Soh B.Y., Goldstein D.R., Matson S., Goodrich S., Markey A.L., Cormier K., Hagerty S.W., Smith K., Ryu H., Ferrante R.J. Modulation of nucleosome dynamics in Huntington's disease. Hum Mol Genet 2007, 16:1164-1175.
141. Steffan J.S., Kazantsev A., Spasic-Boskovic O., Greenwald M., Zhu Y.Z., Gohler H., Wanker E.E., Bates G.P., Housman D.E., Thompson L.M. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 2000, 97:6763-6768.
142. Su D., Cha Y.M., West A.E. Mutation of MeCP2 alters transcriptional regulation of select immediate-early genes. Epigenetics 2012, 7:146-154.
143. Sugars K.L., Brown R., Cook L.J., Swartz J., Rubinsztein D.C. Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis. J Biol Chem 2004, 279:4988-4999.
144. Sun Y., Nadal-Vicens M., Misono S., Lin M.Z., Zubiaga A., Hua X., Fan G., Greenberg M.E. Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell 2001, 104:365-376.
145. Szulwach K.E., Li X., Smrt R.D., Li Y., Luo Y., Lin L., Santistevan N.J., Li W., Zhao X., Jin P. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol 2010, 189:127-141.
146. Takizawa T., Nakashima K., Namihira M., Ochiai W., Uemura A., Yanagisawa M., Fujita N., Nakao M., Taga T. DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain. Dev Cell 2001, 1:749-758.
147. Talbert P.B., Henikoff S. Histone variants - ancient wrap artists of the epigenome. Nat Rev Mol Cell Biol 2010, 11:264-275.
148. Tanner C.M., Ottman R., Goldman S.M., Ellenberg J., Chan P., Mayeux R., Langston J.W. Parkinson disease in twins: an etiologic study. JAMA 1999, 281:341-346.
149. Thomas E.A., Coppola G., Desplats P.A., Tang B., Soragni E., Burnett R., Gao F., Fitzgerald K.M., Borok J.F., Herman D., Geschwind D.H., Gottesfeld J.M. The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice. Proc Natl Acad Sci U S A 2008, 105:15564-15569.
150. Tost J. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Methods Mol Biol 2009, 507:3-20.
151. Tropea D., Giacometti E., Wilson N.R., Beard C., McCurry C., Fu D.D., Flannery R., Jaenisch R., Sur M. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A 2009, 106:2029-2034.
152. Tudor M., Akbarian S., Chen R.Z., Jaenisch R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci U S A 2002, 99:15536-15541.
153. Tweedie-Cullen R.Y., Brunner A.M., Grossmann J., Mohanna S., Sichau D., Nanni P., Panse C., Mansuy I.M. Identification of combinatorial patterns of post-translational modifications on individual histones in the mouse brain. PLoS One 2012, 7:e36980.
154. Ulrey C.L., Liu L., Andrews L.G., Tollefsbol T.O. The impact of metabolism on DNA methylation. Hum Mol Genet 2005, 14:R139-R147.
155. Urdinguio R.G., Fernandez A.F., Lopez-Nieva P., Rossi S., Huertas D., Kulis M., Liu C.G., Croce C.M., Calin G.A., Esteller M. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010, 5:656-663.
156. Urdinguio R.G., Lopez-Serra L., Lopez-Nieva P., Alaminos M., Diaz-Uriarte R., Fernandez A.F., Esteller M. Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One 2008, 3:e3669.
157. Urdinguio R.G., Sanchez-Mut J.V., Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 2009, 8:1056-1072.
158. van Montfoort A.P., Hanssen L.L., de Sutter P., Viville S., Geraedts J.P., de Boer P. Assisted reproduction treatment and epigenetic inheritance. Hum Reprod Update 2012, 18:171-197.
159. van Praag H., Shubert T., Zhao C., Gage F.H. Exercise enhances learning and hippocampal neurogenesis in aged mice. J Neurosci 2005, 25:8680-8685.
160. Villeneuve L.M., Kato M., Reddy M.A., Wang M., Lanting L., Natarajan R. Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes 2010, 59:2904-2915.
161. Villeneuve L.M., Reddy M.A., Natarajan R. Epigenetics: deciphering its role in diabetes and its chronic complications. Clin Exp Pharmacol Physiol 2011, 38:401-409.
162. Voutsinas G.E., Stavrou E.F., Karousos G., Dasoula A., Papachatzopoulou A., Syrrou M., Verkerk A.J., van der Spek P., Patrinos G.P., Stoger R., Athanassiadou A. Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease. Hum Mutat 2010, 31:685-691.
163. Wang S.C., Oelze B., Schumacher A. Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS One 2008, 3:e2698.
164. Watanabe D., Uchiyama K., Hanaoka K. Transition of mouse de novo methyltransferases expression from Dnmt3b to Dnmt3a during neural progenitor cell development. Neuroscience 2006, 142:727-737.
165. Weksberg R., Shuman C., Beckwith J.B. Beckwith-Wiedemann syndrome. Eur J Hum Genet 2010, 18:8-14.
166. Wolf S.A., Melnik A., Kempermann G. Physical exercise increases adult neurogenesis and telomerase activity, and improves behavioral deficits in a mouse model of schizophrenia. Brain Behav Immun 2011, 25:971-980.
167. Wolffe A.P., Matzke M.A. Epigenetics: regulation through repression. Science 1999, 286:481-486.
168. Wood S.H., Craig T., Li Y., Merry B., de Magalhaes J.P. Whole transcriptome sequencing of the aging rat brain reveals dynamic RNA changes in the dark matter of the genome. Age (Dordr) 2012, 4:4.
169. Wu H., Coskun V., Tao J., Xie W., Ge W., Yoshikawa K., Li E., Zhang Y., Sun Y.E. Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 2010, 329:444-448.
170. Wu J., Basha M.R., Brock B., Cox D.P., Cardozo-Pelaez F., McPherson C.A., Harry J., Rice D.C., Maloney B., Chen D., Lahiri D.K., Zawia N.H. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J Neurosci 2008, 28:3-9.
171. Wu Z., Huang K., Yu J., Le T., Namihira M., Liu Y., Zhang J., Xue Z., Cheng L., Fan G. Dnmt3a regulates both proliferation and differentiation of mouse neural stem cells. J Neurosci Res 2012, 90:1883-1891.
172. Yankner B.A., Lu T., Loerch P. The aging brain. Annu Rev Pathol 2008, 3:41-66.
173. Yasojima K., Akiyama H., McGeer E.G., McGeer P.L. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci Lett 2001, 297:97-100.
174. Yasui D.H., Peddada S., Bieda M.C., Vallero R.O., Hogart A., Nagarajan R.P., Thatcher K.N., Farnham P.J., Lasalle J.M. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci U S A 2007, 104:19416-19421.
175. Zainuddin M.S., Thuret S. Nutrition, adult hippocampal neurogenesis and mental health. Br Med Bull 2012, 103:89-114.
176. Zhou V.W., Goren A., Bernstein B.E. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 2011, 12:7-18.
177. Zhou Z., Hong E.J., Cohen S., Zhao W.N., Ho H.Y., Schmidt L., Chen W.G., Lin Y., Savner E., Griffith E.C., Hu L., Steen J.A., Weitz C.J., Greenberg M.E. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 2006, 52:255-269.
178. Zuccato C., Belyaev N., Conforti P., Ooi L., Tartari M., Papadimou E., MacDonald M., Fossale E., Zeitlin S., Buckley N., Cattaneo E. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J Neurosci 2007, 27:6972-6983.
179. Zuccato C., Tartari M., Crotti A., Goffredo D., Valenza M., Conti L., Cataudella T., Leavitt B.R., Hayden M.R., Timmusk T., Rigamonti D., Cattaneo E. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 2003, 35:76-83.